UBXN2A and malignant colon neoplasm: Therefore, we hypothesized that the suppression of the mTORC2 pathway by VTD leads to a reduction in p-AKT473, resulting in a decrease of VEGF in colon cancer cells in a VTD-UBXN2A manner (Fig. 5A).